Skip to content
Offers & competitions
05 May 2021
Oxford’s Vaccitech completes IPO on Nasdaq and raises $110.5m
The Oxford-based clinical-stage biopharmaceutical company that co-invented a COVID-19 vaccine is a spin-out from Oxford University’s Jenner Institute.